Cargando…
Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis
BACKGROUND: The T-helper 17 (Th17) cells have a prominent role in inflammation as well as in bone and join destruction in both rheumatoid and psoriatic arthritis (RA and PsA). Here, we studied Th17 cell differentiation in RA and PsA. METHODS: Blood samples from healthy donors, RA and PsA patients we...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893718/ https://www.ncbi.nlm.nih.gov/pubmed/29670615 http://dx.doi.org/10.3389/fimmu.2018.00606 |
_version_ | 1783313360700309504 |
---|---|
author | Baricza, Eszter Marton, Nikolett Királyhidi, Panna Kovács, Orsolya Tünde Kovácsné Székely, Ilona Lajkó, Eszter Kőhidai, Lászó Rojkovich, Bernadett Érsek, Barbara Buzás, Edit Irén Nagy, György |
author_facet | Baricza, Eszter Marton, Nikolett Királyhidi, Panna Kovács, Orsolya Tünde Kovácsné Székely, Ilona Lajkó, Eszter Kőhidai, Lászó Rojkovich, Bernadett Érsek, Barbara Buzás, Edit Irén Nagy, György |
author_sort | Baricza, Eszter |
collection | PubMed |
description | BACKGROUND: The T-helper 17 (Th17) cells have a prominent role in inflammation as well as in bone and join destruction in both rheumatoid and psoriatic arthritis (RA and PsA). Here, we studied Th17 cell differentiation in RA and PsA. METHODS: Blood samples from healthy donors, RA and PsA patients were collected. CD45RO(−) (naive) and CD45RO(+) (memory) T cells were isolated from peripherial blood mononuclear cell by magnetic separation. Naive T cells were stimulated with anti-CD3, anti-CD28, and goat anti-mouse IgG antibodies and treated with transforming grow factor beta, interleukin (IL)-6, IL-1(β), and IL-23 cytokines and also with anti-IL-4 antibody. IL-17A and IL-22 production were measured by enzyme linked immunosorbent assay, RORC, and T-box 21 (TBX21) expression were analyzed by quantitative polymerase chain reaction and flow cytometry. C-C chemokine receptor 6 (CCR6), CCR4, and C-X-C motif chemokine receptor 3 expression were determined by flow cytometry. Cell viability was monitored by impedance-based cell analyzer (CASY-TT). RESULTS: RORC, TBX21, CCR6, and CCR4 expression of memory T cells of healthy individuals (but not RA or PsA patients) were increased (p < 0.01; p < 0.001; p < 0.05; p < 0.05, respectively) compared to the naive cells. Cytokine-induced IL-17A production was different in both RA and PsA patients when compared to healthy donors (p = 0.0000026 and p = 0.0001047, respectively). By contrast, significant differences in IL-22 production were observed only between RA versus healthy or RA versus PsA patients (p = 0.000006; p = 0.0013454, respectively), but not between healthy donors versus PsA patients. CONCLUSION: The naive CD4 T-lymphocytes are predisposed to differentiate into Th17 cells and the in vitro Th17 cell differentiation is profoundly altered in both RA and PsA. |
format | Online Article Text |
id | pubmed-5893718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58937182018-04-18 Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis Baricza, Eszter Marton, Nikolett Királyhidi, Panna Kovács, Orsolya Tünde Kovácsné Székely, Ilona Lajkó, Eszter Kőhidai, Lászó Rojkovich, Bernadett Érsek, Barbara Buzás, Edit Irén Nagy, György Front Immunol Immunology BACKGROUND: The T-helper 17 (Th17) cells have a prominent role in inflammation as well as in bone and join destruction in both rheumatoid and psoriatic arthritis (RA and PsA). Here, we studied Th17 cell differentiation in RA and PsA. METHODS: Blood samples from healthy donors, RA and PsA patients were collected. CD45RO(−) (naive) and CD45RO(+) (memory) T cells were isolated from peripherial blood mononuclear cell by magnetic separation. Naive T cells were stimulated with anti-CD3, anti-CD28, and goat anti-mouse IgG antibodies and treated with transforming grow factor beta, interleukin (IL)-6, IL-1(β), and IL-23 cytokines and also with anti-IL-4 antibody. IL-17A and IL-22 production were measured by enzyme linked immunosorbent assay, RORC, and T-box 21 (TBX21) expression were analyzed by quantitative polymerase chain reaction and flow cytometry. C-C chemokine receptor 6 (CCR6), CCR4, and C-X-C motif chemokine receptor 3 expression were determined by flow cytometry. Cell viability was monitored by impedance-based cell analyzer (CASY-TT). RESULTS: RORC, TBX21, CCR6, and CCR4 expression of memory T cells of healthy individuals (but not RA or PsA patients) were increased (p < 0.01; p < 0.001; p < 0.05; p < 0.05, respectively) compared to the naive cells. Cytokine-induced IL-17A production was different in both RA and PsA patients when compared to healthy donors (p = 0.0000026 and p = 0.0001047, respectively). By contrast, significant differences in IL-22 production were observed only between RA versus healthy or RA versus PsA patients (p = 0.000006; p = 0.0013454, respectively), but not between healthy donors versus PsA patients. CONCLUSION: The naive CD4 T-lymphocytes are predisposed to differentiate into Th17 cells and the in vitro Th17 cell differentiation is profoundly altered in both RA and PsA. Frontiers Media S.A. 2018-04-04 /pmc/articles/PMC5893718/ /pubmed/29670615 http://dx.doi.org/10.3389/fimmu.2018.00606 Text en Copyright © 2018 Baricza, Marton, Királyhidi, Kovács, Kovácsné Székely, Lajkó, Kőhidai, Rojkovich, Érsek, Buzás and Nagy. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Baricza, Eszter Marton, Nikolett Királyhidi, Panna Kovács, Orsolya Tünde Kovácsné Székely, Ilona Lajkó, Eszter Kőhidai, Lászó Rojkovich, Bernadett Érsek, Barbara Buzás, Edit Irén Nagy, György Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis |
title | Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis |
title_full | Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis |
title_fullStr | Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis |
title_full_unstemmed | Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis |
title_short | Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis |
title_sort | distinct in vitro t-helper 17 differentiation capacity of peripheral naive t cells in rheumatoid and psoriatic arthritis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893718/ https://www.ncbi.nlm.nih.gov/pubmed/29670615 http://dx.doi.org/10.3389/fimmu.2018.00606 |
work_keys_str_mv | AT bariczaeszter distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT martonnikolett distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT kiralyhidipanna distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT kovacsorsolyatunde distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT kovacsneszekelyilona distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT lajkoeszter distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT kohidailaszo distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT rojkovichbernadett distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT ersekbarbara distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT buzaseditiren distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis AT nagygyorgy distinctinvitrothelper17differentiationcapacityofperipheralnaivetcellsinrheumatoidandpsoriaticarthritis |